Ignite Creation Date:
2025-12-26 @ 4:04 PM
Ignite Modification Date:
2025-12-26 @ 4:04 PM
Study NCT ID:
NCT04349306
Status:
COMPLETED
Last Update Posted:
2022-04-25
First Post:
2020-04-13
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
Evaluate the Efficacy and Safety of Rasburicase (Fasturtec®) in the Prevention and Treatment of Hyperuricemia in Pediatric Patients With Non-Hodgkin's Lymphoma and Acute Leukemia
Sponsor:
Sanofi
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2020-05-14
Start Date Type:
ACTUAL
Primary Completion Date:
2021-03-12
Primary Completion Date Type:
ACTUAL
Completion Date:
2021-03-12
Completion Date Type:
ACTUAL
First Submit Date:
2020-04-13
First Submit QC Date:
None
Study First Post Date:
2020-04-16
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2022-04-22
Last Update Post Date:
2022-04-25
Last Update Post Date Type:
ACTUAL